Baoqing Li, M.D.

Baoqing Li, M.D. Specialties: Radiation Oncology

Baoqing Li, M.D.
Specialties: Radiation Oncology
phone icon
checkmark iconAccepting new patients


56-45 Main Street
Flushing, NY 11355

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • Aetna - NYP
  • Empire Blue Cross/Blue Shield
  • Empire Blue Cross/Blue Shield Healthplus
  • GHI
  • Health Insurance Plan of NY (HIP)
  • Oxford Health Plans
  • United Healthcare

about iconabout icon
About Baoqing Li, M.D.

Dr. Baoqing Li is a board certified radiation oncologist and Assistant Professor of Clinical Radiation Oncology at the Weill Cornell Medical College. After earning his Ph.D. in Molecular Biology from the University of Miami School of Medicine in 2000, Dr. Li received his M.D. at New York Medical College in 2005. He completed his residency training in Radiation Oncology at the University of California, Davis Cancer Center, Sacramento, California, where he  was also Chief Resident from 2009-2010. In July 2010, Dr. Li joined the faculty of Radiation Oncology at the Weill Cornell Medical College and was appointed Assistant Professor in August 2011. Dr. Li has been full time Assistant Attending Physician at New York Hospital Queens, where he also serves as the Radiation Safety Champion. His clinical specialties are Head & Neck, Gastrointestinal, Lung, Breast, and Prostate Cancers.  He has an extensive publication in both clinical and basic science research in first-tier peer-reviewed journals. He is also actively involved in teaching and mentoring intern physicians, radiation oncology residents, and dental residents. Dr. Li received two prestigious awards from the ASCO Cancer Foundation and the American Radium Society.A summary of Dr. Baoqing Li’s education, training, awards, and publications is listed as following:TRAININGResident Physician 7/2006 to 6/2010Department of Radiation Oncology,the University of California Davis Cancer CenterSacramento, CaliforniaIntern Physician 7/2005 to 6/2006Department of Internal MedicineFlushing Hospital Medical CenterFlushing, New YorkHONORS AND AWARDSName of award Date awarded1) ASCO Cancer Foundation Merit Award 10/2010from American Society of Clinical Oncology (ASCO)2) Young Oncologist Award 5/2010from American Radium Society3) Prostate Cancer Brachytherapy Fellowship Award (Seattle Prostate Institute) 10/2009from American Brachytherapy Society and American College of Radiation Oncology4) Radiation Oncology Resident Award 2/2009from American College of Radiation Oncology5) Ph.D. Dissertation Merit Award 5/2000from the University of Miami6) Travel Award 4/2005from American Medical Association (AMA)the 30th AMA Medical Student Research ForumPROFESSIONAL MEMBERSHIPS Member/officer Name of Organization Dates held Member American Radium Society 5/1/2008to presentMember American College 2/1/2007of Radiation Oncology to present(ACRO)Member American Society 7/1/2006of Radiation Oncology to present(ASTRO)Member American Association 1/1/1997for Cancer Research to present(AACR) INVITED JOURNAL REVIEWER International Journal of Radiation Oncology, Biology, and PhysicsThoraxBreast DiseaseBMC-CancerINVITED SPEAKER“New Radiation Techniques in the Treatment of Rectal Cancer”. Gastrointestinal Cancers: Update 2011. Columbia University Medical Center GME course, Oct. 2011.“SBRT for inoperable early stage lung cancer”. NYHQ Lung Cancer Symposium, Nov. 2012“Chemotherapy and Survival in Nasopharyngeal Cancer in Asian-Americans”. 6th Annual World Cancer Congress-2013, Xi’an, China, May 2013   SELECTED PUBLICATIONS (PEER-REVIEWED, ORIGINAL RESEARCH ARTICLES)0: Li B., Qi LH, Cress R, Li J, Beckett L, KSC Chao, Chen AM,The impact of chemotherapy on survival among Asian American patients treated with radiation therapy for locally advanced nasopharyngeal carcinoma - Experience from the California Cancer Registry.         Submitted 2014.1: Stessin AM, Sison C, Schwartz A, John Ng, KSC Chao, Li B.Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the Surveillance, Epidemiology, and End Results database.         Cancer 2014 Jul 15 (Epub ahead of print).2: Stessin AM, Sison C, Nieto J, Raifu M, Li B.The role of postoperative radiation therapy in the treatment of meningeal hemangiopericytoma-experience from the SEER database.          Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):784-90.3: Li B, Chen M, Nori D, Chao KS, Chen AM, Chen SL.Adjuvant radiation therapy and survival for pure tubular breast carcinoma--experience from the SEER database.          Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):23-9.4: Chen AM, Farwell DG, Lau DH, Li BQ, Luu Q, Donald PJ.Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?          Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):346-52.5: Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, White de V.Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells.          Prostate. 2011 May;71(6):567-74.6: Chen AM, Hall WH, Li BQ, Guiou M, Wright C, Mathai M, Dublin A, Purdy JA.Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.          Br J Radiol. 2011 Jan;84(997):58-63.7: Li B, Bobinski M, Gandour-Edwards R, Farwell DG, Chen AM.Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation.          Br J Radiol. 2011 Jan;84(997):64-9.8: Chen AM, Li BQ, Farwell DG, Marsano J, Vijayakumar S, Purdy JA.Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.          Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):756-62.9: Chen AM, Li BQ, Lau DH, Farwell DG, Luu Q, Stuart K, Newman K, Purdy JA, Vijayakumar S.Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.          Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1026-32.10: Li B, Li D, Lau DH, Farwell DG, Luu Q, Rocke DM, Newman K, Courquin J, Purdy JA, Chen AM.Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.          Radiat Oncol. 2009 Nov 12;4:52.11: Chen AM, Li BQ, Jennelle RL, Lau DH, Yang CC, Courquin J, Vijayakumar S, Purdy JA.Late esophageal toxicity after radiation therapy for head and neck cancer.          Head Neck. 2010 Feb;32(2):178-83.12: Yang GY, Li B, Wagner TD, Donohue KA, Flaherty L, Kuettel MR.Long-term outcome of stage I seminoma.          Am J Clin Oncol. 2007 Apr;30(2):205-10.13: Li B, Lee MY.Transcriptional regulation of the human DNA polymerase deltacatalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.          J Biol Chem. 2001 Aug 10;276(32):29729-39.14: Wu SM, Zhang P, Zeng XR, Zhang SJ, Mo J, Li BQ, Lee MY.Characterization of the p125 subunit of human DNA polymerase delta and its deletion mutants. Interaction with cyclin-dependent kinase-cyclins.          J Biol Chem. 1998 Apr 17;273(16):9561-9.15: Sun Y, Jiang Y, Zhang P, Zhang SJ, Zhou Y, Li BQ, Toomey NL, Lee MY.Expression and characterization of the small subunit of human DNA polymerase delta.          J Biol Chem. 1997 May 16;272(20):13013-8.


  • Breast Cancer

  • Gastrointestinal Cancer

  • Head and Neck Cancer

  • Lung Cancer

  • Prostate Cancer


  • Degrees: Fudan University (China)
  • Degrees: New York Medical College
  • Degrees: University of Miami
  • Medical School: New York Medical College
  • Residency: New York Medical College

Board Certifications

  • Radiation Oncology

Languages Spoken

  • English